Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.
Intravenous heparin is routinely given after thrombolytic therapy for patients with acute myocardial infarction in the United States and in some, but by no means all, other countries. Several trials have documented improved infarct-artery patency in patients treated with heparin; however, none was l...
Autori principali: | Mahaffey, K, Granger, C, Collins, R, O'Connor, C, Ohman, E, Bleich, S, Col, J, Califf, R |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
1996
|
Documenti analoghi
Documenti analoghi
-
Low-molecular heparins in thrombolytic therapy of myocardial infarction patients
di: I. S. Yavelov
Pubblicazione: (2009-12-01) -
Intravenous thrombolytic therapy in myocardial infarction (review)
di: I I Staroverov
Pubblicazione: (2003-10-01) -
RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
di: Collins, R, et al.
Pubblicazione: (1987) -
RANDOMIZED FACTORIAL TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
di: Collins, R
Pubblicazione: (1987) -
HEPARIN IN THE PRESENCE OR ABSENCE OF ANTIPLATELET THERAPY - AN OVERVIEW OF RANDOMIZED TRIALS IN ACUTE MYOCARDIAL-INFARCTION
di: Macmahon, S, et al.
Pubblicazione: (1992)